.jpg)
.png)
Vol. 14 Issue 1
Letter from the LipidSpin Editors: How I Learned to Stop Worrying and Learned to Love the Guidelines
I’ve been through many stages with the guidelines. I really think I love them now. Let me tell you why. I began my internal medicine residency in 1994, and the first time I ever heard that there was such a thing as guidelines, was at residents’ clinic in my first year where I was treating a man... more
In the strictest sense, “advocacy” is defined as the act or process of supporting a cause. With that as the basis of our discussion, why is advocacy important to a medical specialty organization such as the National Lipid Association (NLA)? The NLA’s mission statement includes comments on... more
Every 39 seconds, a U.S. adult dies from cardiovascular disease (CVD),1 the nation’s top killer and a leading cause of disability for Americans both young and old. We spend about 1 out of 6 healthcare dollars on this disease each year — an estimated nearly $320 billion in healthcare expenses... more
This edition of the LipidSpin is devoted to guidelines vs. guidance. We all strive to practice evidence-based medicine (EBM) and our understanding of science has moved forward at a quick pace. Multiple journals come out every week with new articles that advance medicine’s knowledge base. Large,... more